Sign in
4

Changes in Ownership

X4 Pharmaceuticals, Inc Filed Acc 0001339498-25-000004

Options or other derivatives

  • Executive Chairman acquired 2,329,154 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Craig Adam R Executive Chairman 2025-10-29 Grant or award · Stock Option (right to buy) +2,329,154 2,329,154 D
Loading xslF345X05/wk-form4_1761943322.xml…